CAS RN: 4135-93-7
2,5-Dimethyl-2H-tetrazole
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g
- Available purity: ≥95%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 4135-93-7
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥95% |
2
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
≥95% |
2
In Stock
|
Beijing |
Inquiry |
| 1g |
≥95% |
2
In Stock
|
Hong Kong |
Inquiry |
| 5g |
≥95% |
2
In Stock
|
Shenzhen |
Inquiry |
4135-93-7 / 2,5-dimethyltetrazole
Standard CAS: 4135-93-7
Multi CAS: No
Basic Information
CAS
4135-93-7
Multi CAS
No
Molecular Formula
C3H6N4
Molecular Weight
98.110000
Exact Mass
98.059246
InChI
InChI=1S/C3H6N4/c1-3-4-6-7(2)5-3/h1-2H3
InChIKey
HVRBCXZGTURXBT-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
7
Aromatic heavy atom count
5
Fraction Csp3
0.67
H-bond acceptors
4
Molar refractivity
23.53
TPSA
43.6
LogP / Solubility
WLOGP
-0.48
MLOGP
-0.44
XLogP3
0.5
Consensus LogP
-0.14
Log S (ESOL)
-0.67
Class (ESOL)
Very soluble
Log S (Ali)
-0.02
Class (Ali)
Very soluble
Log S (SILICOS-IT)
0.1
Class (SILICOS-IT)
Highly soluble
ADME
GI absorption
Low
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.66
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5